Why should we need the gut microbiota to respond to cancer therapies?
about
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyMicrobiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.Tuning cancer fate: the unremitting role of host immunity.Faecal microbiota in dogs with multicentric lymphoma.
P2860
Why should we need the gut microbiota to respond to cancer therapies?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Why should we need the gut microbiota to respond to cancer therapies?
@ast
Why should we need the gut microbiota to respond to cancer therapies?
@en
Why should we need the gut microbiota to respond to cancer therapies?
@nl
type
label
Why should we need the gut microbiota to respond to cancer therapies?
@ast
Why should we need the gut microbiota to respond to cancer therapies?
@en
Why should we need the gut microbiota to respond to cancer therapies?
@nl
prefLabel
Why should we need the gut microbiota to respond to cancer therapies?
@ast
Why should we need the gut microbiota to respond to cancer therapies?
@en
Why should we need the gut microbiota to respond to cancer therapies?
@nl
P2860
P50
P356
P1433
P1476
Why should we need the gut microbiota to respond to cancer therapies?
@en
P2093
Giorgio Trinchieri
Romina Goldszmid
P2860
P304
P356
10.4161/ONCI.27574
P577
2014-01-17T00:00:00Z